We are live on ! Find out more
Brown Advisory

Brown Advisory Portfolio holdings

AUM $60.9B
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.8B
AUM Growth
-$5.38B
Cap. Flow
-$124M
Cap. Flow %
-0.42%
Top 10 Hldgs %
21.45%
Holding
1,405
New
73
Increased
464
Reduced
559
Closed
158

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$350M
2
AMZN icon
Amazon
AMZN
+$74.8M
3
DD icon
DuPont de Nemours
DD
+$68.9M
4
IART icon
Integra LifeSciences
IART
+$55.5M
5
EA icon
Electronic Arts
EA
+$51.8M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$408M
2
AOS icon
A.O. Smith
AOS
+$198M
3
BKU icon
Bankunited
BKU
+$60.1M
4
ADBE icon
Adobe
ADBE
+$52.7M
5
RHT
Red Hat Inc
RHT
+$48.8M

Sector Composition

Rank Sector Weight
1 Technology 21.8%
2 Healthcare 16.59%
3 Financials 15.49%
4 Consumer Discretionary 11.76%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPI icon
1226
Intrepid Potash
IPI
$465M
$46K ﹤0.01%
1,783
DNN icon
1227
Denison Mines
DNN
$2.51B
$45K ﹤0.01%
97,054
+28,958
+43% +$16.5K
NXE icon
1228
NexGen Energy
NXE
$6.08B
$42K ﹤0.01%
+23,682
New +$48.5K
CFRX
1229
DELISTED
ContraFect Corporation
CFRX
$38K ﹤0.01%
31
ROX
1230
DELISTED
Castle Brands, Inc.
ROX
$36K ﹤0.01%
42,500
LYG icon
1231
Lloyds Banking Group
LYG
$87.5B
$34K ﹤0.01%
13,519
-11,352
-46% -$32.3K
NYMX
1232
DELISTED
Nymox Pharmaceutical Corp
NYMX
$34K ﹤0.01%
+26,700
New +$48.9K
CARM
1233
DELISTED
Carisma Therapeutics
CARM
$30K ﹤0.01%
1,044
DRRX
1234
DELISTED
DURECT Corp
DRRX
$29K ﹤0.01%
6,000
CVEO icon
1235
Civeo
CVEO
$375M
$28K ﹤0.01%
1,637
+93
+6% +$2.74K
TEN
1236
Tsakos Energy Navigation Ltd
TEN
$1.18B
$27K ﹤0.01%
2,041
AQMS icon
1237
Aqua Metals
AQMS
$9.85M
$26K ﹤0.01%
73
SENS icon
1238
Senseonics Holdings Inc
SENS
$256M
$26K ﹤0.01%
500
SANW
1239
DELISTED
S&W Seed Co
SANW
$25K ﹤0.01%
713
AXAS
1240
DELISTED
Abraxas Petroleum Corp
AXAS
$25K ﹤0.01%
1,164
IDEX
1241
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$24K ﹤0.01%
160
SGYP
1242
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$24K ﹤0.01%
212,947
+747
+0.4% +$490
OIG
1243
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$15K ﹤0.01%
312
MR
1244
DELISTED
Montage Resources Corporation Common Stock
MR
$10K ﹤0.01%
667
NAUH
1245
DELISTED
National American University Holdings, Inc.
NAUH
$4K ﹤0.01%
24,900
BABA icon
1246
CALL
Alibaba
BABA
$277B
$1K ﹤0.01%
900
+300
+50% +$44.4K
BAC icon
1247
CALL
Bank of America
BAC
$438B
$1K ﹤0.01%
29,700
AB icon
1248
AllianceBernstein
AB
$3.54B
-6,655
Closed -$203K
ADNT icon
1249
Adient
ADNT
$1.67B
-37,001
Closed -$1.46M
ADVM
1250
DELISTED
Adverum Biotechnologies
ADVM
-1,058
Closed -$64K

Similar funds

Brown Advisory's Q4 2018 Portfolio in Review

As of Q4 2018, Brown Advisory held 1,405 positions worth $29.8B, down 15% from $35.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Brown Advisory's Q4 2018 filing shows 73 new, 464 increased, 559 reduced and 158 closed positions. Its largest new stake was Integra LifeSciences: 1,012,273 shares worth $45.7M. The largest sale was Meta Platforms (Facebook), an estimated $408M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Brown Advisory's largest Q4 2018 buy was Integra LifeSciences: 1,012,273 shares worth $45.7M.
  • Brown Advisory added most to Microsoft in Q4 2018, an estimated $350M increase.
  • Brown Advisory's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $408M.
  • Brown Advisory fully exited Forest City Realty Trust, Inc. in Q4 2018, selling an estimated $48.5M.
  • Brown Advisory's ten largest holdings make up 21% of its $29.8B portfolio in Q4 2018.
  • Brown Advisory opened 73 new positions and closed 158 in Q4 2018.
  • Brown Advisory's portfolio value fell 15% quarter-over-quarter to $29.8B.

Based on Brown Advisory's 13F filing for Q4 2018, filed 13 Feb 2019.